Investors

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems announces that it has, with the help of the Company’s newly appointed IP lawyers, published the original assignment of the Intellectual Property Rights to the Company as per the Original IP Agreement and Addendum.

The patents acquired as part of the Intellectual Property Rights can be viewed at the following link: 

https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignee?assigneeName=TRUSPINE%20TECHNOLOGIES%20LIMITED

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's admission document dated 19 August 2020.

TruSpine CEO Laurence Strauss commented: “I am delighted to report  that the IP of the Company is held in the name of TruSpine Technologies PLC and can be viewed on the IP website link provided in this announcement. Our thanks go to the team at McCarter & English, LLP for their work in concluding this matter.

“On a personal level, I am pleased that with this matter resolved, the management team can now fully focus on developing the portfolio. In this regard I look forward to reporting on further progress with our FDA 510(k) application for Cervi-LOK."

Enquiries:

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.